← Evidence map

ArticleTranslational lung cancer research2025

A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients.

Nicolas Girard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients. | OpenQuestion